Development of a Cell Free DNA Assay as a Biomarker for Predicting Early Non-response to Therapy in Metastatic Cancer

NCT03892096 · clinicaltrials.gov ↗

COMPLETED

Status

130

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Non-Small Cell Lung Carcinoma
Metastatic Colorectal Cancer
Metastatic Breast Cancer

Interventions

DIAGNOSTIC_TEST: Blood-based cell-free cfDNA qPCR assay

Sponsor

Cadex Genomics